ATE86491T1 - Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. - Google Patents

Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.

Info

Publication number: ATE86491T1
Authority: AT; Austria
Prior art keywords: treatment; diseases; entertain; medication; manufacture
Prior art date: 1986-12-24

Application number

AT87311250T

Other languages

English (en)

Inventor

David Anthony Richards

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-24

Filing date

1987-12-21

Publication date

1993-03-15

1987-12-21 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1993-03-15 Application granted granted Critical

1993-03-15 Publication of ATE86491T1 publication Critical patent/ATE86491T1/de

Links

201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
229960000289 fluticasone propionate Drugs 0.000 title abstract 2
WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title abstract 2
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

AT87311250T 1986-12-24 1987-12-21 Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. ATE86491T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB868630913A GB8630913D0 (en)	1986-12-24	1986-12-24	Pharmaceutical compositions
EP87311250A EP0278174B1 (de)	1986-12-24	1987-12-21	Verwendung von Fluticasonpropionat zur Herstellung eines Präparats zur Behandlung von Darmerkrankungen

Publications (1)

Publication Number	Publication Date
ATE86491T1 true ATE86491T1 (de)	1993-03-15

Family

ID=10609600

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87311250T ATE86491T1 (de)	1986-12-24	1987-12-21	Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.

Country Status (13)

Country	Link
US (1)	US4985418A (de)
EP (1)	EP0278174B1 (de)
JP (1)	JPS63233998A (de)
KR (1)	KR880007084A (de)
AT (1)	ATE86491T1 (de)
AU (1)	AU8296987A (de)
CA (1)	CA1302262C (de)
DE (1)	DE3784693T2 (de)
DK (1)	DK678887A (de)
ES (1)	ES2053571T3 (de)
GB (2)	GB8630913D0 (de)
NZ (1)	NZ223045A (de)
ZA (1)	ZA879464B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5208226A (en) *	1989-09-08	1993-05-04	Glaxo Group Limited	Medicaments
US5270305A (en) *	1989-09-08	1993-12-14	Glaxo Group Limited	Medicaments
US5643602A (en) *	1989-11-22	1997-07-01	Astra Aktiebolag	Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) *	1989-11-22	1989-11-22	Draco Ab	Oral composition for the treatment of inflammatory bowel diseases
IT1256061B (it) *	1992-11-20	1995-11-23		Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
US6166024A (en) *	1995-03-30	2000-12-26	Mayo Foundation For Medical Education And Research	Use of topical azathioprine and thioguanine to treat colorectal adenomas
NL1006774C2 (nl) *	1996-08-14	1998-09-28	Univ Potchefstroom	Anti-atherosclerose- en anti-trombotisch middel en het gebruik daarvan.
DE19732903A1 (de)	1997-07-30	1999-02-04	Falk Pharma Gmbh	Pellet-Formulierung zur Behandlung des Intestinaltraktes
US5993782A (en) *	1998-04-28	1999-11-30	Gardner; Conrad O.	Therapeutic method for reversing hyposmia in a human patient
AU3596199A (en) *	1998-05-06	1999-11-23	Kobenhavns Universitet	Treatment of celiac disease
GB9823036D0 (en) *	1998-10-22	1998-12-16	Glaxo Group Ltd	Fluticasone lotion having improved vasoconstrictor activity
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
US20040023935A1 (en) *	2002-08-02	2004-02-05	Dey, L.P.	Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) *	2002-12-06	2004-06-10	Dey, L.P.	Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20050009848A1 (en) *	2003-07-10	2005-01-13	Icn Pharmaceuticals Switzerland Ltd.	Use of antivirals against inflammatory bowel diseases
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en)	2005-11-12	2012-12-04	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en)	2005-11-12	2014-03-25	The Regents Of The University Of California	Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US20090143343A1 (en) *	2007-11-13	2009-06-04	Meritage Pharma, Inc.	Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) *	2007-11-13	2010-08-26	Meritage Pharma, Inc.	Compositions for the treatment of inflammation of the gastrointestinal tract
EP2214679B1 (de)	2007-11-13	2019-03-27	Meritage Pharma, Inc.	Kortikosteroidzusammensetzungen
CN102238868A (zh)	2008-10-03	2011-11-09	福尔克博士药物有限责任公司	使用颗粒状5-氨基水杨酸治疗肠病的组合物和方法
US20110097401A1 (en) *	2009-06-12	2011-04-28	Meritage Pharma, Inc.	Methods for treating gastrointestinal disorders
NZ624922A (en) *	2009-10-01	2016-05-27	Adare Pharmaceuticals Inc	Orally administered corticosteroid compositions
WO2015034678A2 (en)	2013-09-06	2015-03-12	Aptalis Pharmatech, Inc.	Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CA2902911C (en)	2014-10-31	2017-06-27	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
TWI728172B (zh)	2016-08-18	2021-05-21	美商愛戴爾製藥股份有限公司	治療嗜伊紅性食道炎之方法
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CY1291A (en) *	1980-02-15	1985-10-18	Glaxo Group Ltd	Androstane 17 beta carbothioates
JPS56138200A (en) *	1980-02-15	1981-10-28	Glaxo Group Ltd	Androstane carbothioate compound
US4578221A (en) *	1980-04-23	1986-03-25	Glaxo Group Limited	Androstane carbothioic acids
US4710495A (en) *	1980-07-10	1987-12-01	Otsuka Pharmaceutical Co., Ltd.	Soft steroids having anti-inflammatory activity

1986
- 1986-12-24 GB GB868630913A patent/GB8630913D0/en active Pending
1987
- 1987-12-17 ZA ZA879464A patent/ZA879464B/xx unknown
- 1987-12-21 GB GB8729756A patent/GB2199747B/en not_active Expired - Fee Related
- 1987-12-21 EP EP87311250A patent/EP0278174B1/de not_active Expired - Lifetime
- 1987-12-21 AT AT87311250T patent/ATE86491T1/de not_active IP Right Cessation
- 1987-12-21 ES ES87311250T patent/ES2053571T3/es not_active Expired - Lifetime
- 1987-12-21 DE DE8787311250T patent/DE3784693T2/de not_active Expired - Fee Related
- 1987-12-22 DK DK678887A patent/DK678887A/da not_active Application Discontinuation
- 1987-12-22 NZ NZ223045A patent/NZ223045A/xx unknown
- 1987-12-23 JP JP62324203A patent/JPS63233998A/ja active Pending
- 1987-12-23 US US07/137,169 patent/US4985418A/en not_active Expired - Lifetime
- 1987-12-23 CA CA000555200A patent/CA1302262C/en not_active Expired - Lifetime
- 1987-12-23 AU AU82969/87A patent/AU8296987A/en not_active Abandoned
- 1987-12-24 KR KR870014856A patent/KR880007084A/ko not_active Ceased

Also Published As

Publication number	Publication date
DK678887D0 (da)	1987-12-22
DE3784693T2 (de)	1993-06-17
DE3784693D1 (de)	1993-04-15
DK678887A (da)	1988-06-25
CA1302262C (en)	1992-06-02
GB2199747A (en)	1988-07-20
US4985418A (en)	1991-01-15
GB8630913D0 (en)	1987-02-04
GB2199747B (en)	1990-10-24
EP0278174A3 (en)	1990-06-27
JPS63233998A (ja)	1988-09-29
KR880007084A (ko)	1988-08-26
GB8729756D0 (en)	1988-02-03
NZ223045A (en)	1989-11-28
EP0278174B1 (de)	1993-03-10
ZA879464B (en)	1988-12-28
EP0278174A2 (de)	1988-08-17
AU8296987A (en)	1988-06-30
ES2053571T3 (es)	1994-08-01

Similar Documents

Publication	Publication Date	Title
ATE86491T1 (de)	1993-03-15	Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
DE3772429D1 (de)	1991-10-02	Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
ATE82121T1 (de)	1992-11-15	Arzneimittel fuer die therapeutische behandlung von alopezie.
DE68923819D1 (de)	1995-09-21	Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE3775805D1 (de)	1992-02-20	Arzneimittel zur behandlung periodontaler erkrankungen.
NO870241D0 (no)	1987-01-20	Hypoglykemiske tiazolidindioner.
DE69214467D1 (de)	1996-11-21	Verwendung von Thiazolidin-4-carboxylatderivaten zur Behandlung von Lungenerkrankungen
DE69824576D1 (de)	2004-07-22	Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
ATE191849T1 (de)	2000-05-15	Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
ATE174221T1 (de)	1998-12-15	Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
ATE137116T1 (de)	1996-05-15	Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE69233725D1 (de)	2008-03-27	Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
ATE132749T1 (de)	1996-01-15	Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
ATE74605T1 (de)	1992-04-15	Tetracyclische chinazolinderivate, herstellung und verwendung.
DE69716341D1 (de)	2002-11-21	Verwendung von Alkanoyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen
ATE129895T1 (de)	1995-11-15	Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3686097D1 (de)	1992-08-27	Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE3885022D1 (de)	1993-11-25	Thiosulfinsäurederivate, und die Verwendung von Thiosulfinsäurederivaten zur Herstellung von Arzneimitteln für die Behandlung von Entzündungserkrankungen.
DE3872425D1 (de)	1992-08-06	Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE69300037D1 (de)	1995-02-09	Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
FI925546A7 (fi)	1992-12-07	Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
DE69124415D1 (de)	1997-03-13	Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
ATE42285T1 (de)	1989-05-15	Flaven- und thioflaven-derivate, verfahren zu deren herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung.
NO922635D0 (no)	1992-07-03	Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater

Legal Events

Date	Code	Title	Description
1993-08-15	UEP	Publication of translation of european patent specification
1995-03-15	REN	Ceased due to non-payment of the annual fee